FDA pushes cancer trials to include more elderly people | Science
Older adults make up a hefty proportion of cancer patients but a much smaller slice of clinical trial participants—a long-standing and vexing problem the U.S. Food and Drug Administration (FDA) wants drug companies to tackle. The agency yesterday released recommendations urging companies to boost representation of people over 65 years old, and especially over 75. … Read more